Endothelialization of microporous YIGSR/PEG-modified polyurethaneurea

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Vascular Surgery

Background:

• Developing effective vascular grafts is crucial for treating cardiovascular diseases.
• Polyurethaneurea materials offer potential but require surface modification for improved biocompatibility.
• Enhancing endothelial cell interaction is key to preventing graft failure.

Purpose of the Study:

• To synthesize and fabricate bioactive polyurethaneurea scaffolds modified with PEG and YIGSR peptide.
• To evaluate the mechanical properties and porosity of the fabricated scaffolds.
• To assess the in vitro performance of peptide-modified scaffolds for endothelialization.

Main Methods:

• Gasfoaming and salt-leaching method used for scaffold fabrication.
• Scaffolds characterized for porosity (approx. 78%) and pore size (20-200 microm).
• Mechanical properties (tensile strength) and endothelial cell behavior (attachment, proliferation, ECM production, migration) were assessed.

Main Results:

• Peptide-modified scaffolds exhibited significantly superior mechanical properties (tensile strength 1.4 MPa) compared to peptide-free scaffolds (0.19 MPa).
• Scaffolds demonstrated highly interconnected open pores.
• Confluent endothelial cell monolayers formed on peptide-modified scaffolds, with significantly greater cell attachment, proliferation, ECM production, and migration.

Conclusions:

• Bioactive polyurethaneurea scaffolds modified with PEG and YIGSR peptide show promise for vascular graft applications.
• The YIGSR peptide modification enhances mechanical properties and promotes significant endothelialization.
• These findings suggest a potential for improved vascular graft performance and reduced thrombogenicity.